-
Drugmaker Amgen Lays Off 300 US Employees -
Endo Files for Bankruptcy as US Opioid Litigation Drags -
Japan’s Shionogi Seeks Approval for COVID-19 Pill -
Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds -
Drugmaker Endo Signs $65 Million Opioid Settlement With Florida -
Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug -
Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York -
AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal -
EU Signs Deal With GSK for Supply of Potential COVID-19 Drug -
Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK -
EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers -
Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment -
Allergan’s Bold Patent Move Could Transform Pharma Landscape -
Drugmaker Lilly’s 2016 Forecast Misses Street Expectations